- Home
- WELL vs ABT Comparison
WELL vs ABT Comparison
Compare WELL & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WELL | ABT |
|---|---|---|
| Founded | 1970 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.5B | 189.6B |
| IPO Year | 1994 | 2006 |
Fundamental Metrics
Financial Performance| Metric | WELL | ABT |
|---|---|---|
| Price | $207.73 | $110.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 17 |
| Target Price | ★ $227.09 | $140.24 |
| AVG Volume (30 Days) | 2.9M | ★ 7.1M |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | 1.45% | ★ 2.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.39 | ★ 3.72 |
| Revenue | $10,838,034,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $28.66 | $8.92 |
| Revenue Next Year | $6.03 | $7.39 |
| P/E Ratio | $146.71 | ★ $29.57 |
| Revenue Growth | ★ 35.63 | 5.67 |
| 52 Week Low | $130.29 | $105.27 |
| 52 Week High | $216.43 | $137.49 |
Technical Indicators
Market Signals| Indicator | WELL | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 59.02 | 42.22 |
| Support Level | $182.12 | $105.27 |
| Resistance Level | $209.05 | $113.76 |
| Average True Range (ATR) | 3.71 | 1.86 |
| MACD | -0.92 | -0.08 |
| Stochastic Oscillator | 65.89 | 28.32 |
Price Performance
Historical ComparisonAbout WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,900 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 900 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.